176 related articles for article (PubMed ID: 29908336)
1. Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.
Metrebian N; Weaver T; Pilling S; Hellier J; Byford S; Shearer J; Mitcheson L; Astbury M; Bijral P; Bogdan N; Bowden-Jones O; Day E; Dunn J; Finch E; Forshall S; Glasper A; Morse G; Akhtar S; Bajaria J; Bennett C; Bishop E; Charles V; Davey C; Desai R; Goodfellow C; Haque F; Little N; McKechnie H; Morris J; Mosler F; Mutz J; Pauli R; Poovendran D; Slater E; Strang J
Contemp Clin Trials; 2018 Aug; 71():124-132. PubMed ID: 29908336
[TBL] [Abstract][Full Text] [Related]
2. Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial.
Metrebian N; Weaver T; Goldsmith K; Pilling S; Hellier J; Pickles A; Shearer J; Byford S; Mitcheson L; Bijral P; Bogdan N; Bowden-Jones O; Day E; Dunn J; Glasper A; Finch E; Forshall S; Akhtar S; Bajaria J; Bennett C; Bishop E; Charles V; Davey C; Desai R; Goodfellow C; Haque F; Little N; McKechnie H; Mosler F; Morris J; Mutz J; Pauli R; Poovendran D; Phillips E; Strang J;
BMJ Open; 2021 Jul; 11(7):e046371. PubMed ID: 34210725
[TBL] [Abstract][Full Text] [Related]
3. Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.
Wright NM; Sheard L; Adams CE; Rushforth BJ; Harrison W; Bound N; Hart R; Tompkins CN
Br J Gen Pract; 2011 Dec; 61(593):e772-80. PubMed ID: 22137413
[TBL] [Abstract][Full Text] [Related]
4. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
[TBL] [Abstract][Full Text] [Related]
5. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
McKeganey N; Russell C; Cockayne L
J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).
Potter JS; Marino EN; Hillhouse MP; Nielsen S; Wiest K; Canamar CP; Martin JA; Ang A; Baker R; Saxon AJ; Ling W
J Stud Alcohol Drugs; 2013 Jul; 74(4):605-13. PubMed ID: 23739025
[TBL] [Abstract][Full Text] [Related]
7. A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services.
Day E; Copello A; Seddon JL; Christie M; Bamber D; Powell C; Bennett C; Akhtar S; George S; Ball A; Frew E; Goranitis I; Freemantle N
BMC Psychiatry; 2018 Jan; 18(1):8. PubMed ID: 29334921
[TBL] [Abstract][Full Text] [Related]
8. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
Heidebrecht F; MacLeod MB; Dawkins L
Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial.
Day E; Copello A; Seddon JL; Christie M; Bamber D; Powell C; George S; Ball A; Frew E; Freemantle N
Trials; 2013 Aug; 14():264. PubMed ID: 23958332
[TBL] [Abstract][Full Text] [Related]
10. The Cost-Effectiveness of Financial Incentives to Achieve Heroin Abstinence in Individuals With Heroin Use Disorder Starting New Treatment Episodes: A Cluster Randomized Trial-Based Economic Evaluation.
Shearer J; Metrebian N; Weaver T; Goldsmith K; Strang J; Pilling S; Mitcheson L; Day E; Dunn J; Glasper A; Akhtar S; Bajaria J; Charles V; Desai R; Haque F; Little N; McKechnie H; Mosler F; Mutz J; Poovendran D; Byford S
Value Health; 2023 May; 26(5):658-665. PubMed ID: 36509367
[TBL] [Abstract][Full Text] [Related]
11. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
[TBL] [Abstract][Full Text] [Related]
12. Telephone delivered incentives for encouraging adherence to supervised methadone consumption (TIES): Study protocol for a feasibility study for an RCT of clinical and cost effectiveness.
Metrebian N; Weaver T; Pilling S; Goldsmith K; Carr E; Shearer J; Woolston-Thomas K; Tas B; Getty CA; Cooper C; van der Waal R; Kelleher M; Finch E; Bijral P; Taylor D; Scott J; Strang J
Contemp Clin Trials Commun; 2020 Mar; 17():100506. PubMed ID: 31909291
[TBL] [Abstract][Full Text] [Related]
13. Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES).
Metrebian N; Carr E; Goldsmith K; Weaver T; Pilling S; Shearer J; Woolston-Thomas K; Tas B; Cooper C; Getty CA; van der Waal R; Kelleher M; Finch E; Bijral P; Taylor D; Scott J; Strang J
Pilot Feasibility Stud; 2021 Jan; 7(1):14. PubMed ID: 33407950
[TBL] [Abstract][Full Text] [Related]
14. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
[TBL] [Abstract][Full Text] [Related]
15. The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial.
Jarvis BP; Holtyn AF; DeFulio A; Koffarnus MN; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
Drug Alcohol Depend; 2019 Apr; 197():220-227. PubMed ID: 30852374
[TBL] [Abstract][Full Text] [Related]
16. Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence.
Christensen DR; Landes RD; Jackson L; Marsch LA; Mancino MJ; Chopra MP; Bickel WK
J Consult Clin Psychol; 2014 Dec; 82(6):964-72. PubMed ID: 25090043
[TBL] [Abstract][Full Text] [Related]
17. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
Saulle R; Vecchi S; Gowing L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
[TBL] [Abstract][Full Text] [Related]
18. The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.
Socias ME; Ahamad K; Le Foll B; Lim R; Bruneau J; Fischer B; Wild TC; Wood E; Jutras-Aswad D
Contemp Clin Trials; 2018 Jun; 69():21-27. PubMed ID: 29627621
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
Maas J; Barton G; Maskrey V; Pinto H; Holland R
Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
[TBL] [Abstract][Full Text] [Related]
20. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
